|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/11 | |
| C12N 15/113 | |||
| A61K 31/7125 |
| (11) | Number of the document | 2992096 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14730641.9 |
| Date of filing the European patent application | 2014-04-30 | |
| (97) | Date of publication of the European application | 2016-03-09 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/036136 |
| Date | 2014-04-30 |
| (87) | Number | WO 2014/179445 |
| Date | 2014-11-06 |
| (30) | Number | Date | Country code |
| 201361818441 P | 2013-05-01 | US | |
| 201361818447 P | 2013-05-01 | US | |
| 201361822115 P | 2013-05-10 | US | |
| 201361895708 P | 2013-10-25 | US |
| (72) |
BHAT, Balkrishen, US
|
| (73) |
Regulus Therapeutics Inc.,
10614 Science Center Drive, San Diego, CA 92121,
US
|
| (54) | COMPOUNDS AND METHODS FOR ENHANCED CELLULAR UPTAKE |
| COMPOUNDS AND METHODS FOR ENHANCED CELLULAR UPTAKE |